| In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor. FM Uckun, RK Narla, T Zeren, Y Yanishevski, DE Myers, B Waurzyniak, ... Clinical cancer research: an official journal of the American Association …, 1998 | 108 | 1998 |
| Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study FM Uckun, Z Yang, H Sather, P Steinherz, J Nachman, B Bostrom, ... Blood, The Journal of the American Society of Hematology 89 (10), 3769-3777, 1997 | 88 | 1997 |
| In vivo toxicity, pharmacokinetics, and antileukemic activity of TXU (anti-CD7)-pokeweed antiviral protein immunotoxin. B Waurzyniak, EA Schneider, N Tumer, Y Yanishevski, R Gunther, ... Clinical cancer research: an official journal of the American Association …, 1997 | 75 | 1997 |
| Futbolcularda sürat ve dayanikliliğin solunumsal kapasite üzerine etkisi S Temoçin, R onur Ek, TA Tekin SPORMETRE beden Eğitimi ve Spor bilimleri Dergisi 2 (1), 31-35, 2004 | 70 | 2004 |
| In Vivo Toxicity and Pharmacokinetic Features of the Janus Kinase 3 Inhibitor WHI-P131 [4-(4′Hydroxyphenyl)-Amino-6,7-Dimethoxyquinazoline] FM Uckun, O Ek, XP Liu, CL Chen Clinical cancer research 5 (10), 2954-2962, 1999 | 68 | 1999 |
| Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine … O Ek, P Gaynon, T Zeren, LM Chelstrom, DE Myers, FM Uckun Leukemia & lymphoma 31 (1-2), 143-149, 1998 | 58 | 1998 |
| Protective effects of caffeic acid phenethyl ester on intestinal ischemia-reperfusion injury Y Yildiz, M Serter, RO Ek, K Ergin, S Cecen, EM Demir, C Yenisey Digestive diseases and sciences 54, 738-744, 2009 | 55 | 2009 |
| Targeting SYK kinase‐dependent anti‐apoptotic resistance pathway in B‐lineage acute lymphoblastic leukaemia (ALL) cells with a potent SYK inhibitory pentapeptide mimic FM Uckun, RO Ek, ST Jan, CL Chen, S Qazi British journal of haematology 149 (4), 508-517, 2010 | 54 | 2010 |
| Futbolculara uygulanan bazı motorsal egzersizlerin birbirlerine etkilerinin incelenmesi RO Ek, S Temoçin, TA Tekin, Y Yıldız Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi, 2007 | 45 | 2007 |
| The effects of caffeic acid phenethyl ester (CAPE) on TNBS-induced colitis in ovariectomized rats RO Ek, M Serter, K Ergin, Y Yildiz, S Cecen, T Kavak, C Yenisey Digestive diseases and sciences 53, 1609-1617, 2008 | 40 | 2008 |
| Effects of tamoxifen on myocardial ischemia-reperfusion injury model in ovariectomized rats RO Ek, Y Yildiz, S Cecen, C Yenisey, T Kavak Molecular and cellular biochemistry 308, 227-235, 2008 | 40 | 2008 |
| Pharmacokinetic features, immunogenicity, and toxicity of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin in cynomolgus monkeys. FM Uckun, Y Yanishevski, N Tumer, B Waurzyniak, Y Messinger, ... Clinical cancer research: an official journal of the American Association …, 1997 | 39 | 1997 |
| In vivo biotherapy of HL-60 myeloid leukemia with a genetically engineered recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor … JP Perentesis, R Gunther, B Waurzyniak, Y Yanishevski, DE Myers, O Ek, ... Clinical cancer research: an official journal of the American Association …, 1997 | 37 | 1997 |
| Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group Study FM Uckuna, HN Sather, BJ Waurzyniak, MG Sensel, L Chelstrom, O Ek, ... Leukemia & lymphoma 30 (5-6), 503-514, 1998 | 34 | 1998 |
| Combined therapeutic efficacy of the thymidylate synthase inhibitor ZD1694 (Tomudex) and the immunotoxin B43 (anti-CD19)-PAP in a SCID mouse model of human B-lineage acute … O Ek, GH Reaman, DL Crankshaw, LM Chelstrom, DE Myers, FM Uckun Leukemia & lymphoma 28 (5-6), 509-514, 1998 | 33 | 1998 |
| In vivo toxicity and pharmacokinetic features of B43 (anti-CD19)-genistein immunoconjugate in nonhuman primates. Y Messinger, Y Yanishevski, O Ek, T Zeren, B Waurzyniak, R Gunther, ... Clinical cancer research: an official journal of the American Association …, 1998 | 30 | 1998 |
| Protective effects of citicoline on TNBS-induced experimental colitis in rats RO Ek, M Serter, K Ergin, S Cecen, C Unsal, Y Yildiz, MD Bilgin International journal of clinical and experimental medicine 7 (4), 989, 2014 | 27 | 2014 |
| Treatment of human B-cell precursor leukemia in SCID mice using a combination of the investigational biotherapeutic agent B43-PAP with cytosine arabinoside. Y Messinger, Y Yanishevski, VI Avramis, O Ek, LM Chelstrom, R Gunther, ... Clinical cancer research: an official journal of the American Association …, 1996 | 24 | 1996 |
| The antinociceptive effects of systemic administration of tramadol, gabapentin and their combination on mice model of acute pain ON Aydın, RO Ek, S Temoçin, B Uğur, B Alaçam, S Şen Agri 24 (2), 49-55, 2012 | 19 | 2012 |
| In Vivo., Toxicity and Pharmacokinetic Features of B43 (Anti-CD19)-Genistein Immunoconjugate O Ek, Y Yanishevskic, T Zeren, B Waurzyniak, R Gunther, L Chelstrom, ... Leukemia & lymphoma 30 (3-4), 389-394, 1998 | 19 | 1998 |
Serpil çeçenSağlık Bilimleri Üniversitesi Hamidiye Tıp Fak, Fizyoloji AD在 ku.edu.tr 的电子邮件经过验证
